Bristol-Myers (BMY) offers Eliquis free to Medicaid patients under new pricing pact
I'm PortAI, I can summarize articles.
Bristol-Myers Squibb (NYSE:BMY) offers Eliquis free to Medicaid patients under a new pricing pact. The company, along with other major US and European drugmakers, agreed with President Trump to voluntarily lower certain medicine prices. This initiative aligns with the administration's efforts to better align US drug prices with international standards.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments